Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.
Leonard S. Marks, MD
Advertisement
Articles by Leonard S. Marks, MD
Discovery of the prostate carcinoma-specific gene has led to the development of a promising urine-based laboratory test for the disease.
Advertisement
Latest Updated Articles
- Low-risk prostate cancer well managed with active surveillance
Published: November 1st 2009 | Updated:
- Clinical use of urine PCA3 mRNA testing
Published: September 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Choosing salvage therapy after prostate cancer focal ablation
2
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
3
SUO 2025 data confirm IsoPSA accuracy independent of mpMRI use
4
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
5
